Avantor, Inc.
AVTR
Dr. Gerard Brophy
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Gerard Brophy
Avantor, Inc. reported in an 8-K filed September 26, 2023 that Dr. Gerard Brophy retired as Executive Vice President, Biopharma Production, effective February 29, 2024. Avantor, Inc. reported in an 8-K filed September 26, 2023 that Dr. Gerard Brophy resigned as Executive Vice President, Biopharma Production, effective October 2, 2023.
“Dr. Gerard Brophy, the Company's Executive Vice President, Biopharma Production and a named executive officer in the Company's definitive proxy statement on Schedule 14A filed on March 31, 2023, will be stepping down from that position on October 2, 2023, and retiring from the Company effective February 29, 2024.”
“Dr. Gerard Brophy, the Company's Executive Vice President, Biopharma Production and a named executive officer in the Company's definitive proxy statement on Schedule 14A filed on March 31, 2023, will be stepping down from that position on October 2, 2023, and retiring from the Company effective February 29, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Avantor, Inc. (AVTR)
SEC 8-K
2024-04-03–2024-02-29
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.